BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10037324)

  • 1. Predicting rodent carcinogenicity using potency measures of the in vitro sister chromatid exchange and chromosome aberration assays.
    Schildcrout JS; Margolin BH; Zeiger E
    Environ Mol Mutagen; 1999; 33(1):59-64. PubMed ID: 10037324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. III. Results with 27 chemicals.
    Gulati DK; Witt K; Anderson B; Zeiger E; Shelby MD
    Environ Mol Mutagen; 1989; 13(2):133-93. PubMed ID: 2917552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests.
    Kim BS; Margolin BH
    Environ Mol Mutagen; 1999; 34(4):297-304. PubMed ID: 10618179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative correlation between carcinogenicity and sister chromatid exchange induction in vivo for a group of 11 N-nitroso derivatives.
    Parodi S; Zunino A; Ottaggio L; De Ferrari M; Santi L
    J Toxicol Environ Health; 1983 Mar; 11(3):337-46. PubMed ID: 6842616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the identification of rodent carcinogens by in vitro short-term tests.
    Zeiger E
    Prog Clin Biol Res; 1990; 340D():261-71. PubMed ID: 2371299
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenesis, clastogenesis, carcinogenesis: expectations, correlations and relations.
    Zeiger E; Tennant RW
    Prog Clin Biol Res; 1986; 209B():75-84. PubMed ID: 3529117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxicity testing of fluconazole in vivo and in vitro.
    Yüzbaşioğlu D; Unal F; Yilmaz S; Aksoy H; Celik M
    Mutat Res; 2008 Jan; 649(1-2):155-60. PubMed ID: 18053758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the mudminnow, Umbra sp., in an in vivo sister chromatid exchange test.
    Kligerman AD; Bishop WE; Valentine LC
    Natl Cancer Inst Monogr; 1984 May; 65():111-8. PubMed ID: 6749245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance.
    Zeiger E
    Regul Toxicol Pharmacol; 1998 Oct; 28(2):85-95. PubMed ID: 9927558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dynamics of the frequencies of sister chromatid exchange and chromosome aberrations in vivo].
    Stukalov SV
    Biull Eksp Biol Med; 1988 Aug; 106(8):220-1. PubMed ID: 3137980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between carcinogenicity in rodents and the induction of sister chromatid exchanges and chromosomal aberrations in Chinese hamster ovary cells.
    Rosenkranz HS; Ennever FK; Klopman G
    Mutagenesis; 1990 Nov; 5(6):559-71. PubMed ID: 2263214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of quantitative structure-activity relationship (QSAR) models to predict the carcinogenic potency of chemicals I. Alternative toxicity measures as an estimator of carcinogenic potency.
    Venkatapathy R; Wang CY; Bruce RM; Moudgal C
    Toxicol Appl Pharmacol; 2009 Jan; 234(2):209-21. PubMed ID: 18977375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Technical Report on the toxicity studies of trans-1,2-dichloroethylene (CAS no. 156-60-5) administered in microcapsules in feed to F344/N rats and B6C3F(1) mice.
    Ress NB
    Toxic Rep Ser; 2002 Apr; (55):1-F12. PubMed ID: 12118262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.